Group 1 - EUROAPI published its 2025 Universal Registration Document on March 27, 2026, filed with the French Autorité des marchés financiers (AMF) [1] - The document includes the annual financial report, management report, corporate governance report, sustainability statement, and consolidated statements [5] - The document is accessible on EUROAPI's website and the AMF website, made available to the public under regulatory conditions [1] Group 2 - EUROAPI focuses on reinventing active pharmaceutical ingredients to meet global customer and patient needs, with approximately 200 products in its portfolio [2] - The company has strong R&D capabilities and operates five manufacturing sites in Europe, providing high-quality API solutions in over 80 countries [3] - EUROAPI is committed to advancing public health by securing access to essential active ingredients, employing over 3,000 people [3]
EUROAPI - Availability of the 2025 Universal Registration Document
Globenewswire·2026-03-27 16:45